FDA accepts uniQure's Huntington's gene therapy for priority review, with May decision date
An advisory committee is expected, and approval remains uncertain for the one-time therapy.
Read at Biopharmadive āFull coverage Ā· 15 outlets
- Biopharmadive Ā· lead
- pharmaphorumuniQure set for May FDA verdict on Huntington's gene therapy
- DealroomFDA accepts uniQure's Huntington's gene therapy for priority review
- Huntington's Disease NewsFDA grants priority review to gene therapy for Huntingtonās
- Medical DailyFDA accepts uniQure's one-time Huntington's gene therapy for review-but approval is still uncertain
- HDBuzzFDA sets May 2027 decision date on AMT-130 gene therapy for HD
- BioSpaceUniQure snags May Day decision date for Huntingtonās gene therapy after arduous year
- BioPharm InternationalFDA Accepts uniQureās Huntingtonās Disease Gene Therapy BLA for Priority Review
- Mugglehead Investment MagazineuniQure gains FDA priority review for Huntington's gene therapy
- TradingViewuniQure Wins FDA Priority Review for Huntingtonās Gene Therapy BLA
- BigGo FinanceFDA Opens Review of uniQure's Huntington's Gene Therapy, With May 2027 Verdict Date
- GlobeNewswireuniQure Announces FDA Acceptance and Priority Review of the
- PluangFDA accepts and grants priority review to uniQu...
- Fierce BiotechFDA grants uniQureās Huntingtonās gene therapy priority review, teeing up ādefining milestoneā
- GenomeWebUniQure Huntingtonās Gene Therapy BLA Under FDA Accelerated Review